Krishnan Viswanadhan

Krishnan Viswanadhan, Pharm.D, is a seasoned leader in the pharmaceutical industry with extensive experience spanning over two decades. Currently serving as the Chief Corporate Development and Strategy Officer at Agios Pharmaceuticals since March 2025, Krishnan has also held prominent roles such as President & Chief Operating Officer at Be Biopharma and Senior Vice President of the Global Cell Therapy Franchise at Bristol-Myers Squibb, where responsibilities included leading cross-functional teams and driving key investment decisions. Additionally, Krishnan has served as an independent board member for CARGO Therapeutics and JW Therapeutics, contributing to several committees focused on governance and strategic direction. Education includes an MBA from Cornell University's Johnson Graduate School of Management and a Pharm.D from Rutgers University, alongside a Bachelor of Science in Pharmacy.